Biogen (BIIB) EBT Margin (2009 - 2026)
Biogen's EBT Margin was 4.84% in Q2 2026, down 23.28 percentage points from 28.12% a year earlier and down 10.40 percentage points from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) EBT Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Biogen's EBT Margin was 10.09% through Jun 30, 2026, down 7.90 percentage points year-over-year; for FY2025, it was 15.74%, down 3.96 percentage points from FY2024.
- EBT Margin shows a five-year change of -21.81 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was 19.70% in FY2024 (+6.51 pp), 13.18% in FY2023 (-22.12 pp), 35.31% in FY2022 (+19.41 pp) and 15.89% in FY2021 (-21.65 pp).
- Quarterly EBT Margin has moved between -5.58% (Q3 2023) and 54.66% (Q3 2022) over five years.
- Compared with a year earlier, EBT Margin was higher in three of the last eight quarters, with an average year-over-year change of -1.96 percentage points.
- The best year-over-year quarter for EBT Margin over five years was Q3 2022 (a gain of 44.18 percentage points); the worst was Q3 2023 (a drop of 60.24 percentage points).
- Per Business Quant data, BIIB's EBT Margin in the three quarters before Q2 2026 was 15.24% (Q1 2026), -2.46% (Q4 2025) and 21.99% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | -4.34% |
| 10 | Biogen | 37.51 Bn | 24.16 Bn | 1.96 Bn | 4.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.84% |
| Mar 31, 2026 | 15.24% |
| Dec 31, 2025 | -2.46% |
| Sep 30, 2025 | 21.99% |
| Jun 30, 2025 | 28.12% |
| Mar 31, 2025 | 12.80% |
| Dec 31, 2024 | 11.88% |
| Sep 30, 2024 | 18.29% |
| Jun 30, 2024 | 28.35% |
| Mar 31, 2024 | 20.29% |
| Dec 31, 2023 | 12.22% |
| Sep 30, 2023 | -5.58% |
| Jun 30, 2023 | 28.83% |
| Mar 31, 2023 | 17.80% |
| Dec 31, 2022 | 23.73% |
| Sep 30, 2022 | 54.66% |
| Jun 30, 2022 | 49.03% |
| Mar 31, 2022 | 13.72% |
| Dec 31, 2021 | 14.81% |
| Sep 30, 2021 | 10.48% |
API Access
Biogen EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();